Several studies have demonstrated that IL‐6 levels are effective in distinguishing between active (142.3–148.4 ng/mL) and inactive (114.3–116.2 ng/mL) IBD, although its ability to differentiate between UC and CD remains limited.114. Here, IL6 is linked to inflammatory bowel disease.